← Evidence map

ArticleBMC medical research methodology2025

Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymphoma.

Danilo Di Maio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 39893424